Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)
| 33.55 Delayed Data As of Oct 06 |  -0.91 / -2.64%Today’s Change | 26.81 Today|||52-Week Range 84.83 | -49.40% Year-to-Date |
Latest ARWR News | Press Releases
No recent news for Arrowhead Pharmaceuticals Inc.
Today’s Trading
| Previous close | 34.46 |
| Today’s open | 34.26 |
| Day’s range | 33.20 - 34.79 |
| Volume | 30,690 |
| Average volume (3 months) | 813,505 |
| Market cap | $3.5B |
Data as of 4:00pm ET, 10/06/2022
Growth & Valuation
| Earnings growth (last year) | -61.72% |
| Earnings growth (this year) | +9.64% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +57.16% |
| P/E ratio | NM |
| Price/Sales | 46.84 |
| Price/Book | 8.49 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZLABZai Lab Ltd | -1.56 | -4.21% |
| BPMCBlueprint Medicines ... | -2.19 | -3.37% |
| DNLIDenali Therapeutics ... | -0.24 | -0.76% |
| ---- |
Data as of 4:00pm ET, 10/06/2022
Financials
| Next reporting date | December 13, 2022 |
| EPS forecast (this quarter) | -$0.39 |
| Annual revenue (last year) | $138.3M |
| Annual profit (last year) | -$140.8M |
| Net profit margin | -101.85% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Pasadena, California |
Forecasts
